Related Experiment Videos
CNS granulomatosis in a child with chronic granulomatous disease
1Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel.
Insights
Chronic granulomatous disease (CGD) can affect the central nervous system (CNS), though rare. This case highlights successful treatment of CNS involvement in a child with CGD using a shunt and antifungal medication.
Area of Science:
- Immunology
- Infectious Diseases
- Neurology
Background:
- Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by a defective respiratory burst in phagocytes.
- CGD leads to recurrent, severe infections and granuloma formation across multiple organ systems.
- Central nervous system (CNS) involvement in CGD is uncommon but can be serious.
Observation:
- A pediatric case of CGD with CNS involvement presenting as hydrocephalus is reported.
- Candidal granulomata were identified within the CNS.
- The patient exhibited symptoms of increased intracranial pressure due to hydrocephalus.
Findings:
- The patient's hydrocephalus was successfully managed with a cerebrospinal fluid (CSF) shunt.
- Antifungal therapy was crucial in treating the Candida infection within the CNS granulomata.
- The combined approach led to a positive clinical response.
Implications:
- This case underscores the importance of considering CNS complications in pediatric CGD patients.
- Early diagnosis and appropriate management, including CSF shunting and targeted antifungal therapy, are vital for favorable outcomes.
- Further research into the pathogenesis and optimal treatment strategies for CNS involvement in CGD is warranted.
Abstract:
Chronic granulomatous disease (CGD) is a disease in which a granulomatous process involves various organ systems and in which recurrent infections are seen. The basic defect is the absence of the granulocyte respiratory burst. CNS involvement is rare. We present a report of a child with CGD and CNS involvement, presenting with hydrocephalus. Candida was identified in the granulomata. The patient responded well to a CSF shunt and antifungal therapy.